Effect of Androgel [testosterone] on total and regional adipose tissue and lean body mass in type 2 diabetic patients with hypogonadism.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2015
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacodynamics
- 24 Jun 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 20 Apr 2010 Trial sponsor changed from Solvay Pharmaceuticals to abbott lab as reported by ClinicalTrials.gov.
- 27 Jan 2009 Planned end date changed from 1 Jul 2009 to 1 Jul 2012 as reported by ClinicalTrials.gov.